Status:
RECRUITING
Wearable Devices Faciliate the Management of AMI Patients
Lead Sponsor:
RenJi Hospital
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
18-75 years
Brief Summary
The study will explore the use of wearable technology to consistently monitor patients with acute myocardial infarction (AMI) receiving primary percutaneous coronary intervention (PCI). Parameters suc...
Detailed Description
The aim of this study is to explore in-hospital patient management and predict clinical outcomes in AMI patients receiving primary PCI through wearable technology (e.g., smart watches and wristband de...
Eligibility Criteria
Inclusion
- Aged 18-75 years old
- Diagnosed with STEMI or NSTEMI (ACC/AHA guidelines)
- Half male and half female
- Undergo CAG and PCI treatment;
- Written informed consent.
Exclusion
- People under the age of 18 years old;
- Patients who are pregnant/breastfeeding;
- Patients who are allergic to the metallic or plastic components of the wearable devices
Key Trial Info
Start Date :
April 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06995495
Start Date
April 1 2024
End Date
October 1 2025
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renji Hospital
Shanghai, China, 200127